Latest Updates on Neuromyelitis Optica (NMO) Conference for Healthcare Professionals and Patients

Sunday, November 6, 2016, 7:00 AM - 2:00 PM PST, Cedars-Sinai, 8700 Beverly Blvd, Los Angeles, CA 90048

Registration is now closed. Limited on-site registrations will be available. 

7:30 AM - 2:00 PM

Meeting Location:
Cedars-Sinai Medical Center
Advanced Health Sciences Pavilion
Plaza Level, PEC 4-7
127 S San Vicente Blvd
Los Angeles, CA 90048
Guest Parking: P1, P2 and P4

---

This conference will focus on Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD), rare and poorly understood disorders of the central nervous system that primarily affect the optic nerves and the spinal cord. The exact cause of NMO/NMOSD is unknown and NMO/NMOSD is often misdiagnosed as multiple sclerosis (MS). Optic neuritis causes eye pain or impaired/loss of vision in one or both eyes. Transverse myelitis symptoms include neck or back pain, weakness in arms or legs, numbness, painful muscle spasms, loss of sensation, bladder or bowel dysfunction. NMO/NMOSD can also affect brainstem structures leading to intractable vomiting and hiccups. Children may develop seizures or experience confusion. Led by expert faculty, you will learn about this challenging disorder and the importance of a careful diagnosis and early intervention using the latest medical approaches. A unique feature of this program is a concurrent patient education program conducted in collaboration with The Guthy-Jackson Charitable Foundation.

1. Describe the clinical and laboratory features that distinguish neuromyelitis optica and neuromyelitis spectrum disorder from multiple sclerosis
2. Summarize the diagnostic workup and differential diagnosis for neuromyelitis optica and neuromyelitis spectrum disorder
3. Counsel patients on the importance of a healthy lifestyle to strengthen immune system, increase mobility, and reduce fatigue and depression
4. Recommend participation in clinical trials for patients or family members who meet inclusion criteria
5. Identify which patients would benefit from newer disease-modifying therapies
6. Prescribe appropriate disease modifying therapies for neuromyelitis and neuromyelitis spectrum disorder
7. Describe and apply the new diagnostic criteria for neuromyelitis optica and neuromyelitis optica spectrum disorder

Registration is now closed. Limited on-site registrations will be available. 

Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation Statement 
Cedars-Sinai Medical Center designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

California Assembly Bill 1195

When applicable, course planners and faculty, will incorporate linguistic and/or cultural competency issues relevant to the topic of their presentation. These may include direct communication in the patient-client primary language; understanding and applying the roles that culture, ethnicity, and race play in diagnosis, treatment, and clinical care; and awareness of how the health care providers and patients attitudes, values, and beliefs influence and impact professional and patient relations. (California Assembly Bill Number 1195) For specific information regarding Bill 1195 and definitions of cultural and linguistic competency, please visit http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=200520060AB1195.

Course Materials
All meeting materials will be sent electronically. No hard copies will be available.

Parking

Self-parking is available in visitor parking lots P1, P2 (George Burns Road) or P4 (Sherbourne Drive) for a daily rate of $10.00.
Click here to view campus map.

AMA PRA Category 1 Credit(s)™ (MD, DO) (4.00 hours), Non-Physician AMA Attendance (4.00 hours)

Sunday, November 6, 2016